12 latest endocrinology guidelines/consensus/expert interpretations, one article is included in the bag｜Guideline consensus

Edited by Yimaitong, please do not reprint without authorization.

Guide: This article summarizes the guidelines/consensus/expert interpretations of endocrinology diseases released in April 2021 for everyone to check and download.

 China Type 2 Diabetes Prevention and Control Guidelines (2020 Edition) As the research on type 2 diabetes at home and abroad has made significant progress, more evidence-based medicine has been obtained for the prevention, diagnosis, monitoring and treatment of diabetes and its chronic complications.

The Diabetes Branch of the Chinese Medical Association specially organized experts to revise the original guidelines and formed the "Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 Edition)", which aims to deliver important progress in time and guide clinical practice.

This guide has 19 chapters, covering the epidemiology of diabetes in China, diagnosis and classification of diabetes, tertiary prevention of type 2 diabetes, screening and evaluation of diabetes, education and management of diabetes, comprehensive control goals and high Blood glucose treatment pathways, medical nutrition, exercise therapy and weight management, hyperglycemia drug treatment, diabetes-related technologies, acute and chronic complications of diabetes, hypoglycemia, special conditions of diabetes, metabolic syndrome and traditional Chinese medicine treatment of diabetes, etc.

The issuance of this guideline will help guide and assist clinicians in the standardized and comprehensive management of patients with type 2 diabetes, and improve the clinical outcomes of patients with type 2 diabetes in China.

 Related reading: Professor Lu Juming: Interpretation of the updated key points of the "Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 Edition)" Download link: http://guide.
medlive.
cn/guideline/23047 Chinese Guidelines for the Clinical Diagnosis and Treatment of Diabetic Kidney Disease This guide refers to domestic and foreign Relevant guidelines and expert consensus integrate the clinical experience of Chinese nephrologists, and systematically introduce DKD diagnosis, renal pathological biopsy, treatment and management, management of comorbidities, and the rational application of commonly used drugs.

In addition, the expert team followed the principles of rigor, conciseness, and authority during the compilation process, referred to the format of the international guidelines, put forward the main points of diagnosis and treatment, and listed the explanations one by one.

This guide reflects the new trends and new viewpoints of DKD diagnosis and treatment today.
It is of great value for further strengthening the understanding of DKD, standardizing the DKD diagnosis and treatment system, formulating reasonable treatment principles, guiding precise medication, delaying the progression of kidney disease, and improving the quality of life of patients.
Physicians refer to it in clinical work.

 Related reading: "Diabetic Kidney Disease" Clinical Diagnosis and Treatment Guidelines in China is released, and the recommended points are listed.
Download link: http://guide.
medlive.
cn/guideline/23007 131I Treatment of Graves' Hyperthyroidism Guidelines (2021 version) This guideline is revised to 2013 The version of the guide is the basic reference, adhering to the guiding ideology of innovation, inheritance, and advancing with the times, and recommends based on the research progress and evidence in recent years; it is clinically problem-oriented, and the main increase is the "problem" interpretation part.
Related reading : "131I Treatment of Graves' Hyperthyroidism Guide (2021 Edition)" is released! 41 recommended articles, a summary of the article download link: http://guide.
medlive.
cn/guideline/23152 Expert consensus on clinical medication for diabetic microcirculation disorders (2021 version) Microcirculation disorders are one of the important pathophysiological basis for the occurrence of chronic complications of diabetes One, early intervention can help prevent and treat diabetic vascular complications.

In order to further deepen the understanding of diabetic microcirculation disorders and standardize the reasonable selection of drugs for improving diabetic microcirculation disorders by clinicians, the Diabetes and Microcirculation Professional Committee of the Chinese Microcirculation Society, based on the progress of evidence-based medicine, commented on the "Clinical Use of Diabetic Microcirculation Disorders" The Expert Consensus has been updated.

 Related reading: Two tables to quickly grasp the clinical medication of "diabetic microcirculation disorder" download link: http://guide.
medlive.
cn/guideline/23085 131I treatment of differentiated thyroid cancer guidelines (2021 version) in recent years related to differentiated The 131I treatment concept, treatment methods, follow-up monitoring and evaluation system of thyroid cancer (DTC) after surgery are constantly updated.
Aiming at the incidence and diagnosis and treatment status of DTC in China, the Nuclear Medicine Branch of the Chinese Medical Association organized an expert committee on the "131I treatment of differentiated thyroid cancer guidelines ( 2014 Edition)” was revised, and the “Guidelines for the Treatment of Differentiated Thyroid Cancer with 131I (2014 Edition)” were formulated, with a view to further standardizing and guiding the clinical diagnosis and treatment of DTC with 131I in China.

 Download link: http://guide.
medlive.
cn/guideline/23157 2021 USPSTF Recommendation Statement: Screening for Vitamin D Deficiency in Adults In April 2021, the US Preventive Medicine Task Force (USPSTF) issued recommendations for screening for vitamin D deficiency in adults Statement, this article is an update of the 2014 version of the recommendations, the USPSTF expert group pointed out that the current evidence is insufficient to assess the pros and cons of screening for vitamin D deficiency in asymptomatic adults.

 Download link: http://guide.
medlive.
cn/guideline/23040 Expert consensus on medical ethics in osteoporosis research (2021) Ethics refers to the principles and guidelines that should be followed when dealing with the relationship between people and society.

The medical ethics of osteoporosis research refers to the ethical principles of humanitarianism, independent respect, benefit, non-harm, and fairness that must be followed in osteoporosis research, which is conducive to standardizing, restricting, guiding, and supervising medical behaviors and protecting the rights of patients.

It involves the selection of research subjects in the study, the use and prohibition of drugs, the selection of evaluation indicators, the suspension of the study, the handling of adverse events in the study, etc.

 Download link: http://guide.
medlive.
cn/guideline/23067 "Expert consensus on the treatment and management of comorbidity of tuberculosis and diabetes" Interpretation of the treatment and management of comorbidity of tuberculosis and diabetes has always been a thorny clinical problem, requiring tuberculosis and endocrinology Doctors jointly formulate treatment plans and conduct follow-up management together to further increase the cure rate and reduce the mortality rate.

The Expert Consensus on the Treatment and Management of Co-morbidity of Tuberculosis and Diabetes, published in the first issue of 2021 of the Chinese Journal of Tuberculosis and Diabetes, puts forward specific treatment recommendations on common problems in the treatment and management of co-morbidities of tuberculosis and diabetes.

The author mainly interprets the concept of comorbidity in the consensus, the treatment and management of diabetes during comorbidity, the handling of related adverse drug reactions and precautions, etc.
, for reference and reference for clinical workers engaged in tuberculosis and diabetes in China.

 Related reading: When tuberculosis "hands in" diabetes, these special treatment details should not be ignored.
Download link: http://guide.
medlive.
cn/guidelinesub/8209 2020-2021 ENDO-ERN Consensus Guide: Congenital Hypothyroidism (Updated) Version) The European Reference Network for Rare Endocrine Diseases (ENDO-ERN) has updated the consensus on the management of congenital hypothyroidism.

It mainly provides guidance and recommendations for the diagnosis and treatment of congenital hypothyroidism, and is used to further optimize the detection, diagnosis, treatment and follow-up of children with congenital hypothyroidism.

 Download link: http://guide.
medlive.
cn/guideline/23050 2021 AACE/AHNS Consensus Statement: Children’s Benign and Malignant Thyroid Surgery The American Academy of Clinical Endocrinologists (AACE) and the American Head and Neck Society (AHNS) jointly issued the Consensus statement on malignant thyroid surgery.

The main content involves the surgical basis of pediatric thyroid surgery, complex surgical problems unique to children, and future work.

 Download link: http://guide.
medlive.
cn/guideline/22949 2021 JTA position paper: Management of adult low-risk papillary microcarcinoma of the thyroid (T1aN0M0) The Japanese Thyroid Association (JTA) has released the adult low-risk papillary microcarcinoma of the thyroid (JTA) Opinions on the management of patients with cancer (T1aN0M0).

The incidence of thyroid cancer is on the rise worldwide because of the increase in incidental findings of papillary thyroid microcarcinoma (PTMC).

This article presents evidence of increased incidence of papillary thyroid microcarcinoma and provides guidance for the management of such patients.

 Download link: http://guide.
medlive.
cn/guideline/22930 Clinical Application Guidelines of Chinese Patent Medicines for Treatment of Menopausal Syndrome (2020) Syndrome provides principles and guidance for the selection and use of Chinese patent medicines, which has important guiding significance for improving the clinical efficacy of Chinese patent medicines in the treatment of patients with menopausal syndrome and the rational use of Chinese patent medicines.

 Download link: http://guide.
medlive.
cn/guideline/23185